Revolution Medicines, Inc.

NASDAQ:RVMD

59.1 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Omzet 0000.74203.8247.01415.333.3569.1167.5789.461.1018.69810.1318.75112.66110.02511.54612.08812.50612.28113.16610.347
Kosten van de omzet 012.775118.0212.8582.1451.7732.5332.59969.4552.3342.292.06246.47345.93640.85837.00634.87132.91827.45727.4922.96220.11721.18618.181
Brutowinst 0-12.775-118.021-2.116-2.1452.0514.48112.731-66.0996.7825.2887.398-45.372-37.238-30.727-28.255-22.21-22.893-15.911-15.402-10.456-7.836-8.02-7.834
Brutowinstmarge 000-2.85200.5360.6390.83-19.6960.7440.6980.782-41.21-4.281-3.033-3.229-1.754-2.284-1.378-1.274-0.836-0.638-0.609-0.757
Onderzoek- en ontwikkelingskosten 151.752134.932118.021146.867107.73597.98168.94766.12769.45561.00156.4953.68146.47345.93640.85837.00634.87132.91827.45727.4922.96220.11721.18618.181
Algemene en administratieve kosten 23.9621.71122.83832.24415.51314.6413.22410.9110.43410.2049.0378.6927.7917.2976.675.8255.3415.0915.1714.1623.1032.7252.4163.835
Verkoop- en marketingkosten 000-1.24400000000000000000000
Verkoop-, algemene en administratieve kosten 23.9621.71122.8383115.51314.6413.22410.9110.43410.2049.0378.6927.7917.2976.675.8255.3415.0915.1714.1623.1032.7252.4163.835
Overige kosten 0-12.775-118.021000000000000000000000
Bedrijfskosten 175.712143.86822.838177.867123.248112.62182.17177.03779.88971.20565.52762.37354.26453.23347.52842.83140.21238.00932.62831.65226.06522.84223.60222.016
Bedrijfsresultaat -175.712-156.643-140.859-179.983-123.248-108.797-75.157-61.707-76.533-62.089-57.949-52.913-53.163-44.535-37.397-34.08-27.551-27.984-21.082-19.564-13.559-10.561-10.436-11.669
Bedrijfsresultaat ratio 000-242.5650-28.451-10.715-4.025-22.805-6.811-7.647-5.593-48.286-5.12-3.691-3.894-2.176-2.791-1.826-1.618-1.084-0.86-0.793-1.128
Totaal overige inkomsten en kosten netto 19.42423.4124.85618.78910.94710.4997.0595.0772.9070.8670.3020.2370.2230.2360.2210.2380.330.7110.8880.5950.7410.4420.3050.33
Inkomen voor belasting -156.288-133.233-116.003-161.194-112.301-98.298-68.098-56.63-73.626-61.222-57.647-52.676-52.94-44.299-37.176-33.842-27.221-27.273-20.194-18.969-12.818-10.119-10.131-11.339
Inkomen voor belasting ratio 000-217.2430-25.706-9.709-3.694-21.939-6.716-7.607-5.568-48.084-5.093-3.67-3.867-2.15-2.72-1.749-1.569-1.025-0.824-0.769-1.096
Belastingkosten -156.288000.3433.867-1.773-9.592-0.123-0.297-0.867-0.302-1.8250.2230.2360.2330.3620.347-0.058-0.675-4.3730.7660.470.3350.363
Nettowinst -156.288-133.233-116.003-161.537-108.434-98.298-58.506-56.507-73.329-60.355-57.345-52.676-52.94-44.299-37.176-34.204-27.221-27.215-19.519-14.596-12.818-10.119-10.131-11.339
Nettowinstmarge 000-217.7050-25.706-8.341-3.686-21.85-6.621-7.567-5.568-48.084-5.093-3.67-3.909-2.15-2.715-1.691-1.207-1.025-0.824-0.769-1.096
WPA (Winst Per Aandeel) -0.94-0.81-0.7-1.14-0.99-0.92-0.62-0.63-0.87-0.81-0.77-0.71-0.72-0.6-0.53-0.52-0.42-0.46-0.67-0.4-0.35-0.28-0.28-0.31
Verwaterde WPA -0.94-0.81-0.7-1.14-0.99-0.92-0.62-0.63-0.87-0.81-0.77-0.71-0.72-0.6-0.53-0.52-0.42-0.46-0.67-0.4-0.35-0.28-0.28-0.31
EBITDA -175.712-154.934-139.352-177.125-123.248-108.797-75.157-56.63-71.193-58.888-55.357-52.676-51.189-42.458-35.486-33.828-25.574-25.583-18.629-18.081-11.92-9.28-9.308-10.615
EBITDA ratio 000-238.7130-28.451-10.715-3.694-21.214-6.46-7.305-5.568-46.493-4.881-3.503-3.866-2.02-2.552-1.613-1.496-0.953-0.756-0.707-1.026